UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549
--------------------------------------------------------------------------------


                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE

                         SECURITIES EXCHANGE ACT OF 1934



Date of report (Date of earliest event reported):  November 5, 2003
                                                   ----------------


                         Bio-Imaging Technologies, Inc.
                         ------------------------------
               (Exact Name of Registrant as Specified in Charter)


           Delaware                      1-11182                 11-2872047
--------------------------------------------------------------------------------
(State or Other Jurisdiction     (Commission File Number)      (IRS Employer
    of Incorporation)                                        Identification No.)



826 Newtown-Yardley Road, Newtown, PA                                  18940
--------------------------------------------------------------------------------
(Address of Principal Executive Offices)                             (Zip Code)


                                 (267) 757-3000
                                 --------------
                         (Registrant's telephone number,
                              including area code)



          -------------------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)






ITEM 12.  DISCLOSURE OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

     On November 5, 2003, Bio-Imaging Technologies, Inc. announced its financial
results for the quarter  ended  September  30, 2003.  The full text of the press
release issued in connection  with the  announcement is attached as Exhibit 99.1
to this Current Report on Form 8-K.

     The information in this Form 8-K and the Exhibit  attached hereto shall not
be deemed "filed" for purposes of Section 18 of the  Securities  Exchange Act of
1934 (the  "Exchange  Act") or  otherwise  subject  to the  liabilities  of that
section,  nor shall it be deemed to be  incorporated  by reference in any filing
under the  Securities  Act of 1933 or the Exchange Act,  except as expressly set
forth by specific reference in such a filing.





















                                      -2-



                                    SIGNATURE

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.



                               BIO-IMAGING TECHNOLOGIES, INC.



Dated: November 5, 2003        By: /s/ Mark L. Weinstein
                                  ----------------------------------------------
                                  Name:  Mark L. Weinstein
                                  Title: President and Chief Executive Officer







                                  EXHIBIT INDEX


Exhibit No.                                Description
-----------                                -----------

99.1                                       Press release dated November 5, 2003.